Charles M. Baum

Insider Reports History

Entity
Individual
Location
C/O Mirati Therapeutics Inc., 9393 Towne Centre Drive, Ste 200, San Diego, California
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles M. Baum:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Poseida Therapeutics, Inc. Director Common Stock 78.6K $325K $4.13 Jun 17, 2024 Direct
PMV Pharmaceuticals, Inc. Director Stock Option (right to buy) 67.5K Jun 6, 2024 Direct
Poseida Therapeutics, Inc. Director Stock Option (Right to buy) 27.4K Jun 17, 2024 Direct
Acrivon Therapeutics, Inc. Director Stock Option (Right to Buy) 20.3K Jun 20, 2024 Direct
Mirati Therapeutics, Inc. Founder, President, and CEO, Director Common Stock 0 $59.02 Jan 23, 2024 Direct
Mirati Therapeutics, Inc. Founder, President, and CEO, Director Option to Purchase Common Stock 0 Jan 23, 2024 Direct

Insider Reports Filed by Charles M. Baum

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRV Acrivon Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
PSTX Poseida Therapeutics, Inc. Jun 17, 2024 2 $0 4 Jun 18, 2024 Director
PMVP PMV Pharmaceuticals, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
MRTX Mirati Therapeutics, Inc. Jan 23, 2024 11 $0 4 Jan 23, 2024 Founder, President, and CEO, Director
MRTX Mirati Therapeutics, Inc. Dec 29, 2023 1 $1.2M 4 Jan 3, 2024 Interim CEO, Director
MRTX Mirati Therapeutics, Inc. Aug 9, 2023 1 $2M 4 Aug 10, 2023 Interim CEO, Director
ACRV Acrivon Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 28, 2023 Director
ACRV Acrivon Therapeutics, Inc. Jun 22, 2023 0 $0 3 Jun 28, 2023 Director
PSTX Poseida Therapeutics, Inc. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
PMVP PMV Pharmaceuticals, Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
MRTX Mirati Therapeutics, Inc. Jan 20, 2023 2 $0 4 Jan 24, 2023 President,Founder,Head of R&D, Director
MRTX Mirati Therapeutics, Inc. Jan 4, 2023 1 -$170K 4 Jan 5, 2023 President,Founder,Head of R&D, Director
MRTX Mirati Therapeutics, Inc. Dec 19, 2022 2 -$367K 4 Dec 21, 2022 President,Founder,Head of R&D, Director
MRTX Mirati Therapeutics, Inc. Nov 28, 2022 3 -$5.72M 4 Nov 28, 2022 President,Founder,Head of R&D, Director
PSTX Poseida Therapeutics, Inc. Jun 16, 2022 2 $0 4 Jun 16, 2022 Director
PMVP PMV Pharmaceuticals, Inc. Jun 2, 2022 1 $0 4 Jun 6, 2022 Director
PSTX Poseida Therapeutics, Inc. May 16, 2022 0 $0 3 May 18, 2022 Director
MRTX Mirati Therapeutics, Inc. Jan 14, 2022 5 -$203K 4 Jan 18, 2022 President,Founder,Head of R&D, Director
MRTX Mirati Therapeutics, Inc. Jan 4, 2022 2 -$608K 4 Jan 6, 2022 President,Founder,Head of R&D, Director
MRTX Mirati Therapeutics, Inc. Dec 16, 2021 1 $0 4 Dec 17, 2021 President & CEO, Director
MRTX Mirati Therapeutics, Inc. Dec 3, 2021 9 -$5.89M 4 Dec 3, 2021 President & Head of R&D, Director
MRTX Mirati Therapeutics, Inc. Jun 18, 2021 6 -$6.28M 4 Jun 21, 2021 President & CEO, Director
PMVP PMV Pharmaceuticals, Inc. Jun 2, 2021 1 $0 4 Jun 9, 2021 Director